Skip to Content
Merck
  • Evaluation of urinary oestrogen assays after the menopause and their potential for screening.

Evaluation of urinary oestrogen assays after the menopause and their potential for screening.

Clinica chimica acta; international journal of clinical chemistry (1988-08-15)
M H Rae, P A Mole, C R Paterson
ABSTRACT

Urinary oestrone-3-glucuronide, oestradiol-3-glucuronide, oestrone and oestradiol were measured by radioimmunoassay methods adapted for the very low levels found in postmenopausal women. Oestrogen concentrations related to creatinine in morning urine samples from ten postmenopausal women were found to correlate well with total oestrogen excreted in 24 h (r = 0.934, 0.867, 0.947, 0.909, respectively; p less than 0.002). Day to day variation in five individuals, measured over 5 weeks, showed random fluctuations, with no obvious cyclical variation. Reference ranges, based on two consecutive morning urine samples from 131 postmenopausal women, were 0.73-4.57 mumol/mol creatinine for oestrone-3-glucuronide, 0.66-3.00 mumol/mol creatinine for oestradiol-3-glucuronide, 4.8-30.9 nmol/mol creatinine for oestrone and 3.8-16.8 nmol/mol creatinine for oestradiol. We suggest that such assays may have a part to play in the screening for women at greatest risk of developing osteoporotic fractures.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
β-Estradiol 3-(β-D-glucuronide) sodium salt